Abbvie Inc. vs Johnson & Johnson
ABBV vs JNJ — side-by-side comparison from reported financials. ABBV leads 3, JNJ leads 8 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ABBV | JNJ |
|---|---|---|
| Price | $276.43 | $261.79 |
| Market cap | $488B | $631B |
| Revenue (TTM) | $64.4B | $97.9B |
| Revenue growth | +1.8% | +5.6% |
| Net margin | 9.8% | 21.5% |
| Free cash flow | $18.2B | $22.2B |
| Net cash (debt) | ($56.2B) | ($27.8B) |
| 1-year price return | +19.8% | +37.0% |
| P/E | 77.4 | 29.9 |
| P/E vs own history (cheap-side %) | 23% | 16% |
| Dividend yield | 2.45% | 2.00% |
| Return on equity | 96% | 26% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 140,800 |
Full résumé-style profiles: ABBV CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.